Yearly evolution of organ damage markers in diabetes or metabolic syndrome: Data from the LOD-DIABETES study

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Gomez Marcos, Manuel A ^a   Recio Rodríguez, Jose I ^a   Patino Alonso, Maria C ^b   Agudo Conde, Cristina ^a   Gomez Sanchez, Leticia ^a   Rodriguez Sanchez, Emiliano ^a   Gomez Sanchez, Marta ^a   Garcia Ortiz, Luis ^a  

^a Biomedical Research Institute of Salamanca IBSAL   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Cardiovascular disease; Metabolic syndrome; Subclinical organ damage; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CREATININE; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; BIOLOGICAL MARKER;

ADULT; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EVOLUTION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ORGAN INJURY; PULSE WAVE; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; AGED; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; DISEASE COURSE; FACTUAL DATABASE; HEART MUSCLE; KIDNEY; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; TIME;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIUM; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 80054001309     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-90     Document Type: Article

References (37)

1. Barnett KN, Ogston SA, McMurdo ME, Morris AD, Evans JM. A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland. Diabet Med 2010, 27(10):1124-1129. 10.1111/j.1464-5491.2010.03075.x, 20854379.
2. Kondo T, Osugi S, Shimokata K, Honjo H, Morita Y, Yamashita K, Maeda K, Muramatsu T, Shintani S, Matsushita K, Murohara T. Metabolic syndrome and all-cause mortality, cardiac events, and cardiovascular events: a follow-up study in 25,471 young- and middle-aged Japanese men. Eur J Cardiovasc Prev Rehabil 2011,
3. Sidorenkov O, Nilssen O, Grjibovski AM. Metabolic syndrome in Russian adults: associated factors and mortality from cardiovascular diseases and all causes. BMC Public Health 2010, 10:582. 10.1186/1471-2458-10-582, 2955695, 20920226.
4. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med 2011, 171(5):404-410. 10.1001/archinternmed.2011.2, 21403036.
5. Sehestedt T, Olsen MH. Subclinical organ damage and cardiovascular risk prediction. Blood Press 2010, 19(3):132-139. 10.3109/08037051.2010.483054, 20429694.
6. Xu L, Jiang CQ, Lam TH, Lin JM, Yue XJ, Cheng KK, Liu B, Jin YL, Zhang WS, Thomas GN. The metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: the Guangzhou Biobank Cohort Study-CVD. Clin Endocrinol (Oxf) 2010, 73(2):181-188.
7. Somaratne JB, Whalley GA, Poppe KK, Ter Bals MM, Wadams G, Pearl A, Bagg W, Doughty RN. Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community. Cardiovasc Diabetol 2011, 10(1):29. 10.1186/1475-2840-10-29, 3094210, 21492425.
8. Havranek EP, Froshaug DB, Emserman CD, Hanratty R, Krantz MJ, Masoudi FA, Dickinson LM, Steiner JF. Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity. Am J Med 2008, 121(10):870-875. 10.1016/j.amjmed.2008.05.034, 2574427, 18823858.
9. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004, 351(13):1285-1295. 10.1056/NEJMoa041365, 15385655.
10. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Jama 2001, 286(4):421-426. 10.1001/jama.286.4.421, 11466120.
11. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, Folsom AR, Hirsch AT, Dramaix M, deBacker G, Wautrecht JC, Kornitzer M, Newman AB, Cushman M, Sutton-Tyrrell K, Lee AJ, Price JF, d'Agostino RB, Murabito JM, Norman PE, Jamrozik K, Curb JD, Masaki KH, Rodriguez BL, Dekker JM, Bouter LM, Heine RJ, Nijpels G, Stehouwer CD, Ferrucci L, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. Jama 2008, 300(2):197-208. 2932628, 18612117.
12. Einarson TR, Hunchuck J, Hemels M. Relationship between blood glucose and carotid intima media thickness: A meta-analysis. Cardiovasc Diabetol 2010, 9:37. 10.1186/1475-2840-9-37, 2929218, 20707887.
13. Faeh D, William J, Yerly P, Paccaud F, Bovet P. Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity. Cardiovasc Diabetol 2007, 6:32. 10.1186/1475-2840-6-32, 2148037, 17958881.
14. Brohall G, Oden A, Fagerberg B. Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med 2006, 23(6):609-616. 10.1111/j.1464-5491.2005.01725.x, 16759301.
15. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010, 55(13):1318-1327. 10.1016/j.jacc.2009.10.061, 20338492.
16. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010, 121(4):505-511. 10.1161/CIRCULATIONAHA.109.886655, 2836717, 20083680.
17. Kim YJ, Cho BM, Lee S. Metabolic syndrome and arterial pulse wave velocity. Acta Cardiol 2010, 65(3):315-321. 10.2143/AC.65.3.2050348, 20666270.
18. Tentolouris N, Papazafiropoulou A, Moyssakis I, Liatis S, Perrea D, Kostakis M, Katsilambros N. Metabolic syndrome is not associated with reduction in aortic distensibility in subjects with type 2 diabetes mellitus. Cardiovasc Diabetol 2008, 7:1. 10.1186/1475-2840-7-1, 2235836, 18171473.
19. Nomura K, Hamamoto Y, Takahara S, Kikuchi O, Honjo S, Ikeda H, Wada Y, Nabe K, Okumra R, Koshiyama H. Relationship between carotid intima-media thickness and silent cerebral infarction in Japanese subjects with type 2 diabetes. Diabetes Care 2010, 33(1):168-170. 10.2337/dc09-0453, 2797965, 19808915.
20. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl 1):S62-69. 2797383, 20042775.
21. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112(17):2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
22. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Jama 1997, 277(11):925-926.
23. Gomez-Marcos MA, Recio-Rodriguez JI, Rodriguez-Sanchez E, Castano-Sanchez Y, de Cabo-Laso A, Sanchez-Salgado B, Rodriguez-Martin C, Castano-Sanchez C, Gomez-Sanchez L, Garcia-Ortiz L. Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol. BMC Public Health 2010, 10:143. 2858115, 20298558.
24. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25(6):1105-1187. 10.1097/HJH.0b013e3281fc975a, 17563527.
25. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007, 23(1):75-80. 10.1159/000097034, 17108679.
26. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ckd EPI. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150(9):604-612. 2763564, 19414839.
27. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995, 25(2):417-423. 10.1016/0735-1097(94)00371-V, 7829796.
28. Martin-Moreno JM, Boyle P, Gorgojo L, Maisonneuve P, Fernandez-Rodriguez JC, Salvini S, Willett WC. Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 1993, 22(3):512-519. 10.1093/ije/22.3.512, 8359969.
29. Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet CP, Vinueza R, Torres M, Hernandez R, Wilson E. Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol 2009, 8:52. 10.1186/1475-2840-8-52, 2760519, 19781089.
30. Lacy PS, O'Brien DG, Stanley AG, Dewar MM, Swales PP, Williams B. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens 2004, 22(10):1937-1944. 10.1097/00004872-200410000-00016, 15361765.
31. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010, 31(19):2338-2350. 2948201, 20530030.
32. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008, 51(4):527-539. 10.1007/s00125-007-0918-3, 18239908.
33. Ito H, Komatsu Y, Mifune M, Antoku S, Ishida H, Takeuchi Y, Togane M. The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol 2010, 9:18. 10.1186/1475-2840-9-18, 2877657, 20470427.
34. Dachun X, Jue L, Liling Z, Yawei X, Dayi H, Pagoto SL, Yunsheng M. Sensitivity and specificity of the ankle--brachial index to diagnose peripheral artery disease: a structured review. Vasc Med 2010, 15(5):361-369. 10.1177/1358863X10378376, 20926495.
35. Potier L, Abi Khalil C, Mohammedi K, Roussel R. Use and utility of ankle brachial index in patients with diabetes. Eur J Vasc Endovasc Surg 2011, 41(1):110-116. 10.1016/j.ejvs.2010.09.020, 21095144.
36. Barrios V, Calderon A, Coca A, Gonzalez-Juanatey JR, Sarria A, Rodriguez-Padial L. Computerized interpretation of the electrocardiogram in the diagnosis of left ventricular hypertrophy. The ELECTROPRES project. Rev Clin Esp 2011, 211(8):391-399.
37. Rodriguez-Poncelas A, Quesada Sabate M, Coll De Tuero G, Caula Ros J, Gelada-Batlle E, Gomez-Marcos MA, Garre-Olmo J, Garcia-Ortiz L, Comalada Daniel C, Ramos Blanes R. Prevalence of occult chronic kidney disease and associated variables in a population of patients with type 2 diabetes. Med Clin (Barc) 2010, 134(6):239-245.